<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Naveen Rao on Medium]]></title>
        <description><![CDATA[Stories by Naveen Rao on Medium]]></description>
        <link>https://medium.com/@naveen101?source=rss-fc9c3de75975------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*dG5iu4iBmabUVRcT5F9S4Q.gif</url>
            <title>Stories by Naveen Rao on Medium</title>
            <link>https://medium.com/@naveen101?source=rss-fc9c3de75975------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Fri, 20 Nov 2026 12:29:33 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@naveen101/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[2024 Neurotech Funding Snapshot]]></title>
            <link>https://medium.com/@naveen101/2024-neurotech-funding-snapshot-bc3aa48e4fa3?source=rss-fc9c3de75975------2</link>
            <guid isPermaLink="false">https://medium.com/p/bc3aa48e4fa3</guid>
            <category><![CDATA[brain-health]]></category>
            <category><![CDATA[brain]]></category>
            <category><![CDATA[neuromodulation]]></category>
            <category><![CDATA[neurotechnology]]></category>
            <category><![CDATA[brain-computer-interface]]></category>
            <dc:creator><![CDATA[Naveen Rao]]></dc:creator>
            <pubDate>Mon, 10 Mar 2025 15:38:39 GMT</pubDate>
            <atom:updated>2025-03-10T15:38:39.301Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*H6srYWaCIMORMOfG.png" /><figcaption>Please use this to support your commercial strategy! Cite as follows: “Neurotech Futures’ 2024 Funding Snapshot. https://rb.gy/fic5so”</figcaption></figure><h3>🤑 $2.3 Billion Across 129 Deals: Analyzing a (historic) year of fundraising</h3><h4>👉 <a href="https://neurotechnology.substack.com/p/2024-funding-snapshot">Full Analysis Available Here!</a></h4><p>2024 was a <a href="https://rb.gy/fic5so">breakout year</a> for commercial neurotech.</p><p>From January to December last year, I curated <a href="http://neurotechnology.substack.com/">2,000+ developments</a> spanning fundraising, regulatory, commercial news, as well as industry, societal, and research topics, along with lots of other stuff in this Substack.</p><p>After some cleanup, enrichment, and analysis, I’m excited to share this original <strong>Neurotech Funding Snapshot</strong> of 129 deals from 2024.</p><p><em>Note: I mostly stopped writing on Medium in favor of a more writer-friendly platform in </em><a href="http://neurotechnology.substack.com/"><em>Substack</em></a><em>. For more </em><a href="https://neurotechnology.substack.com/p/2024-funding-snapshot"><em>free analysis of this funding snapshot</em></a><em>, free biweekly updates shipped straight to your inbox, as well as various options to access to my paywalled content (including a no-cost referral program) make sure to sign up today.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=bc3aa48e4fa3" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Beyond Mindfulness: “Hella Focused,” the Neuroscience of Ecstasis, and the Joy of Work]]></title>
            <link>https://medium.com/@naveen101/beyond-mindfulness-hella-focused-the-neuroscience-of-ecstasis-and-the-joy-of-work-960e3135b8d?source=rss-fc9c3de75975------2</link>
            <guid isPermaLink="false">https://medium.com/p/960e3135b8d</guid>
            <category><![CDATA[creativity]]></category>
            <category><![CDATA[neuroscience]]></category>
            <category><![CDATA[flow]]></category>
            <category><![CDATA[brain]]></category>
            <category><![CDATA[productivity]]></category>
            <dc:creator><![CDATA[Naveen Rao]]></dc:creator>
            <pubDate>Wed, 14 Jun 2023 18:42:02 GMT</pubDate>
            <atom:updated>2023-06-14T19:03:18.389Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*-x0olbYUU6nE-Rx3.jpg" /></figure><h4>Embracing the limits of limitlessness</h4><p>You know the feeling. You lose track of time. You’re so engrossed in what you’re doing, and it feels so good — actually, it feels awesome. Not a single thing can pry you away from the task at hand.</p><p>Throughout history, humans have sought ways to unlock this latent potential and scale the pinnacles of cognitive performance. Plato described “Anamnesis,” a state of transcendent understanding. Ideas flow, time stops, creativity surges. You just do, without thinking. For my entire adult life, I’ve held this mystical ‘flow state’ with reverence approaching awe.</p><p>There were those obsessive few years where I chased this state whenever I sat down to write, eventually training myself through sheer perseverance to appreciate the struggle of just showing up and trying, not getting overly fixated on the output. For the most part, the results were mixed. Sometimes “the muse” would alight on my shoulder, and more oftentimes, not.</p><blockquote>“Our normal waking consciousness… is but one special type of consciousness, whilst all about it, parted from it by the flimsiest of screens, there lie potential forms of consciousness entirely different.” — William James</blockquote><h4>Help for the Bored at Work</h4><p>In the scientific age, we’ve given a new name to this state of being: <a href="https://en.wikipedia.org/wiki/Ecstasy_(philosophy)"><strong>Ecstasis</strong></a>. Defined as a state of ‘beyond consciousness’, ecstasis refers to those rare moments where we feel completely absorbed in our tasks, transcending our ordinary perception of time, space, and self.</p><p>Neuroscientists have opened the hood to demystify this process. A cascade of neurotransmitters — your brain’s internal messengers — flood the brain. Dopamine, known for its central role in our internal reward system, gives us a sense of pleasure and satisfaction, while anandamide, a lesser-known player helps with pain regulation (which, perhaps, I’ve experienced as an ‘out of body’ feeling) and new idea generation.</p><p>As we’re beginning to understand, the real shift induced by these chemicals happens in our brainwaves.</p><p>Ever been so bored that every second feels like a minute, every minute an hour? You’re reading this, but aren’t you supposed to be working on that thing? You’re cycling through tabs, stuck in procrastination, monotony, or maybe you’re braindead from an endless carousel of meetings.</p><p>When you’re “checked out,” your brain is likely dominated by Beta waves, the high-frequency brainwaves associated with our normal waking state when we are alert but not particularly engrossed.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*MdN00lFd314ECKhQ.jpg" /><figcaption>Image from <a href="https://www.diygenius.com/the-5-types-of-brain-waves/">DIYGenius (along with a helpful primer!)</a></figcaption></figure><p>During Ecstasis, we switch gears from the high-frequency Beta waves to the boundary of Alpha and Theta waves. This transition mirrors the brainwave changes often seen during deep meditation or just before sleep and allows us to delve into a realm of heightened creativity and problem-solving. Overthinking temporarily stops — a phenomenon called “<a href="https://www.psychologytoday.com/us/blog/the-edge-peak-performance-psychology/201703/the-transient-hypofrontality-edge#">transient hypofrontality.</a>”</p><p>Or, a layperson might say, hella focused.</p><p>This understanding of brain states is fueling the rise of industries aimed at enhancing cognitive performance. EEG sensors, designed to monitor these shifts in brainwaves. Then there’s the psychedelic medicine market, anticipated to grow significantly in the coming years, relying on substances that can profoundly alter brainwave patterns and states of consciousness. Don’t forget the surge in mindfulness apps, personal coaching, self-help books, wellness influencers, and nootropics to name a few— all forming multi-multi billion-dollar industries.</p><p>(And then, there’s the <a href="https://medium.com/sub-con/elon-musks-neuralink-just-got-fda-approval-for-human-trials-now-what-789a097b38fc">real dystopian industry of literal brain-hacking </a>.)</p><p>In their book “Catching Fire,” Steven Kotler and Jamie Wheal estimate the total size of the “Altered States Economy” — money spent trying to get out of our own heads — as exceeding <strong><em>$4 Trillion</em></strong> a year.</p><p>Those numbers may seem silly, unfathomable even, but to me their qualitative importance speaks to our most human trait: our limits. It seems that society’s quest for cognitive flow is growing even bigger in our increasingly fragmented, distraction-addled rat race.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*nDEOu12-cxpk7f1H.jpg" /><figcaption>Children….the ultimate creative constraint</figcaption></figure><h4>Limits of Limitlessness….Player 3 has entered the game</h4><p>Ever since I became a new parent last year, my open-ended schedule has evaporated. The late nights, the leisurely weekends, the pre-dawn creative hours — all are now (mostly) a thing of the past. Today, my work schedule is rigid, a natural constraint imposed by the duties of parenthood and the schedule of our nanny.</p><p>While this shift and the broad psychological transformations of fatherhood have certainly played a central role in my determination and ‘grit,’ I’ve also begun to adopt a more intentional lens to observe myself working over days, weeks, and months — a sort of meta-meditation.</p><p>As my quest to “unlock my ultimate self” has begun softening into something light and fun, more like a video game, rather than a gritty, stoic battle or “War of Art,” it works much better. As Nathaniel Hawthorne wrote, “We go all wrong, by too strenuous a resolution to go all right.” I mean, as a word-nerd, I feel like based on the name alone, “ecstasis” should … feel good….right?</p><p>The multi-billion dollar industry race to dissect and tinker with our cognitive abilities seems to forget the joy of exploration. Capitalism’s hammer typically overlooks the joyfulness of the process of discovery, in search of the nail of efficient outputs. What’s too often lost in the rush for productivity is the playful interactions and exploration of our selves, our inner lives, and our relationship with work.</p><p><em>Interested in the business of productivity and the future of the neurotechnology industry? Sign up for our forthcoming </em><a href="https://www.patchwiselabs.com/neurofeedback"><strong><em>market research report</em></strong></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=960e3135b8d" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Elon Musk’s Neuralink just got FDA approval for human trials. Now what?]]></title>
            <link>https://medium.com/@naveen101/elon-musks-neuralink-just-got-fda-approval-for-human-trials-now-what-789a097b38fc?source=rss-fc9c3de75975------2</link>
            <guid isPermaLink="false">https://medium.com/p/789a097b38fc</guid>
            <category><![CDATA[biotechnology]]></category>
            <category><![CDATA[neuroscience]]></category>
            <category><![CDATA[digital-health]]></category>
            <category><![CDATA[elon-musk]]></category>
            <category><![CDATA[neuralink]]></category>
            <dc:creator><![CDATA[Naveen Rao]]></dc:creator>
            <pubDate>Fri, 09 Jun 2023 18:22:36 GMT</pubDate>
            <atom:updated>2023-08-15T09:28:18.312Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*vwxdfkB3CIp_HF0M.jpg" /></figure><h4>Exploring the Business and Ethical Implications of Brain-Computing Interface (BCI) Innovation</h4><p>You may have seen <a href="https://www.reuters.com/science/elon-musks-neuralink-gets-us-fda-approval-human-clinical-study-brain-implants-2023-05-25/">this news</a> a few weeks ago. Founded by Elon Musk in 2016, <a href="https://neuralink.com/">Neuralink</a> entered the industry with a brain-computer interface (BCI) called the Link — an electrode-studded chip sewn into the surface of the brain to connects it to external computing— as well as a robotic device that implants the chip.</p><p>They’ve emerged as a significant player in the neurotechnology field. Following the company’s public debut in 2019, it made substantial strides in its research, including successful <a href="https://www.youtube.com/watch?v=DVvmgjBL74w">pig</a> and <a href="https://www.youtube.com/watch?v=rsCul1sp4hQ">monkey</a> trials in 2020 and 2021, respectively. Their first application for FDA approval was <a href="https://www.reuters.com/investigates/special-report/neuralink-musk-fda/">rejected </a>in 2022 citing human safety concerns and scrutiny over animal treatment and regulatory hurdles.</p><p>So, what does Neuralink’s achievement of this crucial milestone mean?</p><h4>1. Regulatory Hurdles and Ethical Concerns</h4><p>While the FDA approval for human trials is a step forward for Neuralink, Kip Ludwig, former program director for neural engineering at the U.S. National Institutes of Health, “optimistically” expects Neuralink to take at least 10 more years to commercialize its brain implant. Competitors like Synchron have been working on brain computer interfaces for <a href="https://www.fiercebiotech.com/medtech/synchron-implants-brain-computer-interface-first-us-patient-paralysis-trial">years</a>. Furthermore, Neuralink is currently under investigation by the U.S. Department of Agriculture for potential animal-welfare violations, highlighting the stringent oversight and potential obstacles that accompany the development of such revolutionary technologies.</p><p>Neuralink’s innovative endeavors are not without controversy. The initial FDA rejection of Neuralink’s human trial application cited safety reasons, which involved potential issues with the product’s lithium battery and the risk of damage to brain tissue. The company has also been subject to criticism over its treatment of animal subjects during testing, with alleged ‘needless suffering and deaths’ among pigs, sheep, and monkeys leading to a federal investigation.</p><p>The scrutiny Neuralink is facing underscores the complex nature of blending technology and biology, and the need for more comprehensive and stringent regulation in the field of neurotechnology. The lack of concrete plans for data safety, especially in the context of storing and processing sensitive brain data, further accentuates this regulatory need.</p><h4>2. Implications for Healthcare Commercialization</h4><p>According to Musk, Neuralink’s brain implant technology aims to help treat a variety of conditions including obesity, autism, depression, and schizophrenia, with more modest short-term objectives of aiding paralyzed patients to communicate without typing. However, Physicians Committee for Responsible Medicine expressed concerns, urging Neuralink to shift to noninvasive brain-computer interfaces to avoid surgical complications and potential infections.</p><p>The envisioned applications range from treating mental health conditions to assisting individuals with neurodegenerative disorders. Globally, over 264 million people suffer from depression, and approximately 3.5 million people in the U.S. live with an autism spectrum disorder. If successfully developed and commercialized, Neuralink’s brain chip could significantly impact these populations and the associated markets, which are projected to reach $18.3 billion for depression treatment and $4.5 billion for autism services in the U.S. alone by 2026.</p><h4>3. Business Valuations and Expert Skepticism</h4><p>Neuralink, recently saw its <a href="https://www.reuters.com/technology/musks-neuralink-valued-about-5-bln-despite-long-road-market-2023-06-05/">valuation rise</a> dramatically from $2 billion to approximately $5 billion based on privately executed stock trades, on the heels of FDA approval. As Sim Desai, Chief Executive of Hiive, an online platform where the shares are traded, noted, demand for Neuralink stock has been “tremendous,” demonstrating the potential investor interest in this sector.</p><p>Neuralink’s secondary trades have driven its valuation increase, deviating from the trend where pre-IPO companies are valued at an average discount of 47% to their last funding round, according to data provider Caplight. Despite investor interest, some experts remain skeptical about Neuralink’s value. For instance, Arun Sridhar, a scientist and entrepreneur specializing in neuromodulation, deemed Neuralink’s valuation “bonkers” given the early stage of its clinical development: “A study to assess safety and tolerability is in no shape or form valid to justify a $5 billion valuation”</p><h4>4. Big Picture Questions and Considerations</h4><p>The FDA’s approval of Neuralink’s human trials brings us closer to a future where humans interface directly with machines, a proposition that raises profound questions around ethics, societal implications, and the future of human cognition. As we edge closer to a potential era of human-cyborg hybrids, the role of companies like Neuralink and their profit-driven pursuits in shaping this future warrants close scrutiny and robust regulatory oversight.</p><p>Neuralink’s long-term goal, as stated by Musk, is not limited to medical applications, but extends to enhancing human capabilities and helping humans coexist with advancing AI.</p><p>The issues surrounding animal testing and treatment also raise questions about the ethical responsibilities of tech firms venturing into biomedical research. In a field traditionally dominated by rigorous scientific protocols and ethical guidelines, the rapid advancement and “Silicon Valley” style approach may lead to potential lapses in established practices.</p><blockquote>“The brain is not just another organ…Mental privacy is the sanctuary of our minds, and should be protected at the global level.” — <a href="https://www.forbes.com/sites/roberthart/2023/06/05/elon-musks-neuralink-wants-to-put-chips-in-our-brains---how-it-works-and-who-else-is-doing-it/">Rafael Yuste, Columbia University Neurobiologist</a></blockquote><p>Despite the controversy, the promise of such technology is undoubtedly interesting. Dystopia has become so commonplace that it’s easy to overlook the downsides of opening up this pandora’s box. In our quest to unlock human potential, we should not inadvertently create a world where the ability to access such enhancements leads to new forms of inequality, or even a world where such enhancements become a requirement rather than a choice.</p><p><em>Interested in the future of brain-computing interfaces (BCI) and the neurotechnology industry? Sign up for our forthcoming </em><a href="https://www.patchwiselabs.com/neurofeedback"><strong><em>market research report</em></strong></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=789a097b38fc" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Coaching and Self-Coaching]]></title>
            <link>https://medium.com/@naveen101/coaching-and-self-coaching-53b77bacadc4?source=rss-fc9c3de75975------2</link>
            <guid isPermaLink="false">https://medium.com/p/53b77bacadc4</guid>
            <category><![CDATA[coaching]]></category>
            <category><![CDATA[therapy]]></category>
            <category><![CDATA[writing]]></category>
            <category><![CDATA[professional-development]]></category>
            <category><![CDATA[careers]]></category>
            <dc:creator><![CDATA[Naveen Rao]]></dc:creator>
            <pubDate>Tue, 12 Apr 2022 19:24:56 GMT</pubDate>
            <atom:updated>2022-04-18T22:12:01.004Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/960/0*-8V5bDX28cU7JebL.jpg" /></figure><h4>Outsourcing help can beget self-acceptance</h4><p>In seasons of transition, making adjustments effectively is key.</p><p>As a self-aware type like many of you, keeping journal(s) and holding space throughout the margins of the week to reflect, ruminate, regroup, and so on, ostensibly towards betterment — that’s just part of the process.</p><p>So too, are regular “un-plugging” periods to take a big step back, take meaningful time away from work or routine, and take stock of my life whole-hog. Am I enjoying the mudpit of life? Do I need to make some adjustments to my technique or outlook to more fully squelch?</p><p>Working with a professional coach is something I’ve gradually explored doing over the last ~2 years. In the initial pause of early COVID, I did a bit of research to find someone to help me reorient my lens on “work” — a poorly defined genre in my life that includes but is not limited to concepts such as professionalism, money, entrepreneurship, my personal brand, a 5-year-plan, personal finances, and at least one other Big Serious Topic that we’ll get into shortly.</p><h4>Outsource that Sh*t</h4><p>I finally met with my coach yesterday and after about 30 minutes of conversation I stumbled into a powerful moment of trust, in myself and in them. Accepting that the details are important with those aforementioned topics, I admitted to my coach, and to myself, that actually, despite my nervousness and uncertainty, the big picture for just about every item on that list is that it’s perfectly fine, and might, in fact, be actually pretty great.</p><p>Not bad for a first call.</p><p>What is coaching? It’s <a href="https://coactive.com/blog/the-difference-between-coaching-and-therapy/">different from therapy</a>, but it’s more immediate than a self-help book or a Tony Robbins youtube video. Like therapy, it’s as much about the time with the trained professional as it is about the time between sessions. But it’s more akin to a personal trainer helping rehab from an injury — which in my current case is also happening at this juncture.</p><p>That’s not all. I’ve also begun to work with a finance professional to help turn my DIY personal money management system into a long-term source of stability for my family. I sort of know what I don’t know, sort of, but maybe not. So, I’m outsourcing it to a pro — or, I will be soon.</p><h4><strong>Everything in its right place</strong></h4><p>Going back to college, I’d try to organize my life into these various buckets: social, academic, physical fitness, and so on. Now that I’m All Grown Up (™), I’m finding that the last two decades of compartmentalization has meant holding onto all of the details of all the things I’m doing, all by myself, is actually holding on to the stress of it all, which has taken its toll on my physical and mental health, not to mention my relationships, my work, my creative pursuits, and all other areas of my life.</p><p>As I peel off these ossified layers of anxiety, one by one, slowly, deliberately, gently even, and put myself into the hands of a professional, I’m already finding a new well of space opening up at or around my core. I feel lighter, more positive, more lucid. Sort of like a metaphysical Marie Kondo effect.</p><p>In my soul maybe? It feels damn good, is what I’m saying.</p><h4>The Juice is Loose</h4><p>Which leaves me with more wherewithal, or presence of mind, or JUICE, to attend to that other Big Serious Topic I mentioned: Creative Writing. In part, I will be working on that with my coach — how to gain confidence in my creative writing career. Tactically, this includes things like writing down a career plan and developing a view of all the work that I am doing, and have been doing for the last seven years or so, in terms of writing, networking, learning, and building up my “artist CV.”</p><p>But more strategically, I realized I want to use this extra space I’ve begun unlocking within myself to become my own writing coach. To see myself as a creative writer and not a wannabe, an amateur, a daydreamer, or a poser. Someone who can help myself to become <strong>more steady, consistent, and skillful as a writer as well as an active literary citizen of the world</strong>, whatever that means. I’m still figuring it all out, yo.</p><p>This will eventually span everything from making sure I am clear (or at least seeking truth) outside of my fiction writing, on the ‘nonfiction of’ my own politics, sexuality and gender norms, cultural and emotional baggage, professional baggage (a.k.a. cynicism), and honestly, a bunch of other crap that exceeds the focus of this particular ramble.</p><ul><li>What helpful self-coaching tools or exercises have you used?</li><li>What resources or professional services/products would you recommend?</li><li>What are your thoughts or approaches to the idea of “unlearning?”</li></ul><p>Thanks for reading.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=53b77bacadc4" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[How should I create annual writing goals?]]></title>
            <link>https://medium.com/@naveen101/how-should-i-create-annual-writing-goals-659b86493edd?source=rss-fc9c3de75975------2</link>
            <guid isPermaLink="false">https://medium.com/p/659b86493edd</guid>
            <category><![CDATA[writing]]></category>
            <category><![CDATA[goals]]></category>
            <category><![CDATA[self-improvement]]></category>
            <category><![CDATA[new-years-resolutions]]></category>
            <category><![CDATA[purpose]]></category>
            <dc:creator><![CDATA[Naveen Rao]]></dc:creator>
            <pubDate>Thu, 30 Dec 2021 22:56:19 GMT</pubDate>
            <atom:updated>2021-12-30T22:56:19.796Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*K4ZpplpgBnrxYC1x" /></figure><h4>Hint: That’s the wrong place to start</h4><blockquote>“Clarity of mission is a powerful cornerstone of success. Knowing what you want gives direction to your life — every word, every action, every association, can be accurately chosen and harnessed to precipitate your desired outcome. What you eat, when you sleep, where you go, who you talk to, what you allow them to say to you, who your friends are, can all be corralled and launched toward your wildest dreams.” — Will Smith, Will (p. 214)</blockquote><p>There are pithy, universal essays about the writing process. This is not one of them.</p><p>This is a personal exploration I’m writing as an act of discovery and accountability. I don’t guarantee it will make any sense to you at all. You don’t have to read it. So why am I writing it? Well, writing is one of those anomalies, an unparalleled perfection of balance of thought and action, so by writing this in public (hitting “publish”), I’m striving to write my way towards my writing goals. Like laying down the track as you go. Like I said, not pithy. Let’s get into it.</p><p>Without vomiting up the entire backstory of my life and writing dreams, suffice to say I’ve been on a journey as a writer. We can skip the overstuffed act one-two-three structure and just start the tape at the dawn of the pandemic, when burnout as an entrepreneur led (read: forced) me into a sabbatical from my decade-plus career as a journeyman healthcare analyst and blogger.</p><p>I focused my entire being into therapy, creative writing, and physical rehabilitation for a bum achilles. It turns out intention and hard work pay off: 20+ months later I’ve transformed my sense of self as a creative writer, and rebooted* my body, mind, finances, career, and relationships around that new identity.</p><p>*Apparently, this “reboot” is one of those painful kinds that requires multiple restarts and loading screens, because perhaps I’m actually in the process of installing a new OS upstairs. My psyche and sense of identity still feels like a bag of parts, or an island of misfit toys at the time of this writing, rather than some unified and cohesive sense of self-as-writer or writer-as-self.</p><p>If you’re totally lost by now, like I said, you really don’t need to be reading this. There’s more stimulating content pretty much anywhere on the interwebs. It’s just that — I need to write it, and know why I’m writing it. Which brings us back to those goals.</p><p>As Tony Robbins has shouted into my memory, <strong>FINDING YOUR WHY </strong>is the most important part of motivation-building and goal-setting. So before exploring how to set my goals, or what goals I should set, I’ll deliberate here on <strong>WHY</strong> am I writing about my writing goals. Why do I want to set goals? Isn’t the joy of writing enough?</p><ul><li>To gain clarity on my ambitions and dreams beyond just “I want to be a writer.”</li><li>To expand my sense of self-as-writer beyond just creative writing, or business writing about business and healthcare. To connect those two things to a bunch of other things.</li><li>To span genres, explore new styles, push the boundaries of my craft and trade so that when I say I’m a writer, I really believe it. So that it’s not a question of day job versus hobby, but a conviction. Ikigai fits the bill:</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/770/0*QXmlm4rE6vmWC0eN.png" /></figure><ul><li>To boost my confidence in writing about my writing, which I’ve learned will help me dramatically as I try to “make it” as a published writer, apply to conferences, workshops, residencies, mentorships, fellowships, and publishers. But I’m interested in more than just playing the game with agents and publishers and editors; my real “why” is to go deeper and challenge my own understanding of craft, my creative process, and my own “theory of fiction.” To understand what I’m writing, where it’s coming from and why, and where that rabbit hole goes to…or comes from…</li><li>To create a learning framework that sets me onto a career-and-life-altering trajectory, i.e. getting better at getting better. Using writing as the magic process for myself to explore and expand my subject matter, style, and purpose, intentionally and discretely. Hippie-dippie “The Secret” stuff? You betcha.</li><li>To learn more about screenwriting and film adaptations of prose so I can position myself to break into those kinds of project opportunities by studying them with intention and learning my way into the game.</li><li>To organize my historically messy/sprawling/poorly defined goals around both reading and writing into a project framework that I can assemble, brick by brick, into something that provides me structure, protection, a platform, or other stuff.</li><li>To expand my sense of purpose in writing, to better understand how I feel I can and should show up in the world as a person, as a man, as a creative, as a dare-I-say, artist.</li><li>To reinforce and affirm that what I am doing is important to me, and reinforce and affirm that what I am doing is an important thing to be doing at all, or even more important than doing other things (like making money).</li><li>To know what I am writing for, and who I am writing for, and learn how to develop a fluid outlook on those things, based on ongoing dialogue with an evolving kaleidoscope of people, ideas, topics, media, rather than as a fixed and rigid sense of self, position, perspective.</li><li>To practice writing and develop my voice.</li><li>To really stop giving a shit about what other people will think. To grow comfortable dancing with my words like nobody’s watching.</li></ul><p>So — Now that I have my murky sense of purpose in the above list, how do I set up specific goals in a way that sets me up in turn to accomplish them over the course of a calendar year? Here are a few thoughts based on what I’ve learned as a fail-forward, real-world-MBA/MFA-sort-of writer over the last decade-plus.</p><h4><strong>First:</strong> Review what “data” you have</h4><p>It’s useful as heck to review past writing goals. None of the stuff on that list happens overnight. In fact, this whole exercise itself is the result (too early to call it a culmination) of years of frenzied self-improvement strategery. So, I used the last 20 months as a dataset of goals versus results, intention &amp; achievements, as well as a bit of 80/20 analysis (what 20 percent of the efforts generated 80 percent of the “results” I feel good about?).</p><p><strong>There’s no wrong way to do this, except of course not to do it at all</strong>. My meta-level takeaway: The more organized I become with my goals, the fuller a picture of the results I’ll be able to see. Measure → manage, etc.</p><h4>Second: Imagine tangible results</h4><p>With goopy existential self-improvement stuff like this, it’s useful as heck to refine these impulses into the most concrete, tangible results you can imagine. For this too I’ve relied on Tony Robbins’ <a href="https://www.youtube.com/watch?v=n_yV3KBzxx4">RPM method</a> as a pinhole exercise that forces me to weave my loose threads together into a singularly focused purpose.</p><p>Mine this year will be to <strong>create a single project that serves as a “container” for numerous, and hitherto disparate and disorganized goals</strong>. Spoiler alert: you’re looking at <a href="https://medium.com/sub-con">part of it</a> right now. If I focus on executing on this one project for the whole year, I’ll be damn-near guaranteed to end the year off closer to the above objectives.</p><h4><strong>Third: Set up accountability</strong></h4><p>Ensure there’s an accountability mechanism, because otherwise it’s not going to get consistently done. This one’s super important because it balances out my fire-in-belly ambition with the tempering disappointment of innumerable failed goals, rejections, and disappointments from years past.</p><p>The fact of the matter is that writing is intrinsically solitudinal. I just made that word up! But it’s true. If achieving your goals comes down to reliance on willpower or discipline or intensity of desire alone, there will be some lapses. Maybe not for you, but sure as heck for me. If it’s just me “pushing” — it’s a matter of time before I get lazy, I get demotivated, I get despondent, or I justify other priorities, and my progress lapses.</p><p>Which is also, by the way, part of the process.</p><p>2021 was the closest I’ve ever come to consistent month over month diligence. Honestly, I did pretty great, going from zero to five published short stories in a single year. But in ’22 I’m changing the game up: My <strong>accountability will be to my writing community of a handful of specific people with whom I’ve been sharing my work in an ad-hoc way for months.</strong> The aforementioned “single project” will be targeted at these individuals, which introduces a component of <strong>social accountability</strong> (the “pull” to complement my “push”) that I will be enhancing with some <strong>financial accountability </strong>as well.</p><h4>Fourth: Don’t overthink it…</h4><p>…and don’t be afraid to break your own rules. This whole article is an example of me overthinking it, and thus breaking this very rule about overthinking it. Don’t overedit. Don’t overanalyze. Don’t be like past (and let’s be honest, present) me. Just freaking write. I’m not trying to be clever here — it’s important to relinquish a degree of control. This is art, not science. At least it is for me. It’s gonna get messy, and it’s gonna get weird. At least it will for me.</p><p>That’s all I got for now. If you’re a random stranger on the interwebs who’s read this despite my disclaimers and protestations, and you want to stay looped in, feel free to <a href="https://medium.com/sub-con">follow this pub</a> for more random writerly writings. Or don’t. I’m not doing this for you. ❤</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=659b86493edd" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Friends with Benefits: MA Plans Weigh in on Social Determinants]]></title>
            <link>https://medium.com/tincture/friends-with-benefits-ma-plans-weigh-in-on-social-determinants-975c2a14b348?source=rss-fc9c3de75975------2</link>
            <guid isPermaLink="false">https://medium.com/p/975c2a14b348</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[medicare]]></category>
            <category><![CDATA[social-determinants]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[innovation]]></category>
            <dc:creator><![CDATA[Naveen Rao]]></dc:creator>
            <pubDate>Mon, 05 Aug 2019 16:27:25 GMT</pubDate>
            <atom:updated>2019-08-05T16:27:25.994Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/420/0*8hyEXIPoXNM_4ROZ" /><figcaption>Source: <a href="http://www.patchwiselabs.com/wiki">Patchwise Labs</a></figcaption></figure><h4>How does Medicare Advantage feel about Supplemental Benefits, Community Partners, and SDOH?</h4><p>Supplemental Benefits for Social Determinants have become a trending topic in healthcare, well in advance of the new rule’s 2020 start date. As a <a href="https://medium.com/patchwiselabs/who-what-how-understanding-mas-new-sdoh-payments-7e4243a84941">quick recap</a>, the new Supplemental Benefits program in Medicare Advantage (MA) will improve plans flexibility to spend on services and programs to support members’ social determinants of health (SDOH).</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/546/1*w65_Ftptg6_G0Q2vBjbDiA.png" /><figcaption><a href="https://medium.com/patchwiselabs/who-what-how-understanding-mas-new-sdoh-payments-7e4243a84941">Who, What, and How: Understanding Supplemental Benefits for SDOH</a></figcaption></figure><p>Despite widespread excitement, general expectations for the program in the first year remain lukewarm. While SDOH remains a hot topic, we’re still in the <a href="https://medium.com/patchwiselabs/the-early-innings-managed-care-markets-for-social-determinants-of-health-sdoh-innovation-e4a2336e2f77">early innings</a> of market maturity. Plans are now actively trying to figure out what their strategy should look like. <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2737895">A new paper published in JAMA</a> provides a closer look at MA plan sentiments around the <a href="https://medium.com/patchwiselabs/the-2020-opportunity-medicare-advantage-as-a-market-for-sdoh-innovation-b337e7685cdb">new “SSBCI” benefit</a>.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fupscri.be%2F582c01%3Fas_embed%3Dtrue&amp;dntp=1&amp;display_name=Upscribe&amp;url=https%3A%2F%2Fupscri.be%2F582c01%2F&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=upscri" width="800" height="400" frameborder="0" scrolling="no"><a href="https://medium.com/media/b38aab6dac72745bddf6773c7a051a4b/href">https://medium.com/media/b38aab6dac72745bddf6773c7a051a4b/href</a></iframe><p>To understand MA Plans’ sentiments about this new opportunity, authors interviewed 38 leaders from 17 plans across the country of varying size, quality, and geographic location. While these data were collected in 2018 and may likely be slightly dated, they represent one of the only such assessments to date. Some of their key findings:</p><p>There seemed to be <strong>unanimous consensus</strong> that SDOH is a key pillar of their population health strategies moving forward. But when it came to how to address SDOH through this program, sentiments differed in two camps:</p><h3>Some MA Plans Want to Address SDOH Directly</h3><p>One group was keen on <strong>addressing SDOH directly</strong> by offering supplemental benefits to members in the form of new programs or services, or expansion of existing initiatives.</p><p>They discussed the opportunities presented to design targeted benefits to patient subgroups (a new option enabled by the <a href="http://www.snpalliance.org/media/1222/uniformity-requirements-and-benefit-flexibility-changes.pdf">uniformity</a> rule change). Some of them mentioned that “it’s the right thing to do,” particularly in light of triple aim goals of cost, quality, and member experience.</p><p>Plans also commented about the potential to increase their enrollment by making their plans more attractive to members. Anthem reportedly saw a 14% increase in enrollment in the first quarter alone, partially attributed to new benefits.</p><h3>Some MA Plans Want to Partner with CBOs</h3><p>The second group was leaning towards <strong>partnering with and referring to community-based organizations (CBOs) </strong>to address SDOH, rather than doing it directly.</p><p>They spoke to the importance of collaboration and the desire not to duplicate CBOs existing efforts and expertise. While the paper didn’t go into a great amount of operational detail, some respondents described building an aggregate resource hub for internal care managers to refer out, while other discussed writing grants to invest in CBOs as a way of promoting sustainability.</p><p>This last point is slightly problematic on face, as consensus from SDOH experts suggests that relying on grant-funded programs is the opposite of sustainability. A better option that several groups around the country are actively exploring would involve <a href="https://medium.com/patchwiselabs/announcing-the-2018-buyers-guide-to-social-innovation-tech-for-health-a3777181334e">measuring CBO performance through technology platforms</a> and including them in value-based payments.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*KTm_QmItfYNXfrvrX35QFA.jpeg" /><figcaption><a href="https://medium.com/patchwiselabs/announcing-the-2018-buyers-guide-to-social-innovation-tech-for-health-a3777181334e">Source: Patchwise Labs Buyer’s Guide for Social Innovation Technology</a></figcaption></figure><h3>Either Way, Challenges Abound</h3><p>To be clear, the choice of offering programs directly versus partnering externally is probably a false distinction: Most plans will have to go both ways. Existing programs and services such as home visits or <a href="https://medium.com/patchwiselabs/let-food-be-thy-medicine-an-ancient-idea-driving-the-business-of-food-innovation-in-health-care-3052b9a135cd">medically tailored meals</a> could easily be ramped up with the added payment flexibility, while plans partner up to address loneliness, <a href="https://medium.com/patchwiselabs/new-cms-rules-for-non-emergency-transportation-who-wins-who-loses-d1f685603851">transportation needs</a>, or other SDOH.</p><p>Either way, both groups described conflicting pressures as they devised their strategy for supplemental benefits. All plans reported a few key areas of concern:</p><ul><li><strong>Return on Investment (ROI)</strong>: Plans remain in the dark about the details of how these programs and services fit into their financial books, which is a key criterion for figuring out <a href="https://medium.com/patchwiselabs/a-glimpse-into-the-near-future-of-financing-the-social-determinants-of-health-sdoh-95102ce31407">pricing, benefit design, and bidding</a>.</li><li>Specifically, plans wondered whether investing in new supplemental benefits will result in cost-savings; How to identify certain high-cost subgroups to tailor custom benefits, as per the new flexibility allowance; Which benefits or services carry the strongest evidence of impact; How these new programs might impact their star ratings and therefore bonus/penalty payments.</li><li><strong>Benefit Design and Eligibility</strong>: Plans reported that members switching plans frequently (“churn”), as well as high variability of partners, payments and patients across counties, as well as a host of other factors made benefit design even more complex to plan for in advance.</li><li><strong>Finding the right CBO partners</strong>: Plans’ ideal requirements to partner with CBOs include: The ability and capacity to scale services; Evidence of success and ability to deliver, especially to avoid members filing grievances that could affect star ratings; Willingness to “share the risk of providing a new benefit.” Plans generally reported feeling more comfortable building on existing relationships rather than developing new partnerships.</li></ul><h3>Timing Is Everything, and We Ain’t There Yet</h3><p>The biggest caveat to this paper: The survey was conducted in 2018, following the passage of the law, but preceding the <a href="https://medium.com/patchwiselabs/who-what-how-understanding-mas-new-sdoh-payments-7e4243a84941">publication of the final rule</a>. Participants would have understandably been reluctant to move forward at that time with program development until CMS had published key details.</p><p>However, with those details now published, and the program going into effect on January 1 2020, it appears that the above concerns, challenges, and complexities are all more valid than ever. Beyond the rule itself, CMS is running an experiment on <a href="https://www.cms.gov/newsroom/fact-sheets/value-based-insurance-design-model-vbid-fact-sheet-cy-2020?source=post_page---------------------------">value-based insurance design</a> that includes supplemental benefits for social supports as well; this will inform how some of these policies work n the real world.</p><p>Anecdotally, we’ve heard from investors, consultants, technology vendors, and even some health plan executives themselves that 2020 will be a year of “wait and see,” to gather evidence of what works and doesn’t, and to see how the various efforts around the country (e.g. <a href="https://twitter.com/naveen101/status/1143546302204170240">Centene’s Social Health Bridge</a>) begin shaping up.</p><p>Here are <strong>Three Key Questions</strong> on our mind as we enter the second half of the year:</p><ol><li><strong>Will CMS penalize marketing?</strong> Questions remain around member engagement and the <a href="https://medium.com/patchwiselabs/the-2020-opportunity-medicare-advantage-as-a-market-for-sdoh-innovation-b337e7685cdb">nearly invisible line CMS has drawn</a> between making sure people know about these new benefits (which is encouraged) and making sure plans are not using these new benefits to market their plans to people (which is illegal). It doesn’t appear to be slowing down plans but time will tell how zealous CMS is about enforcement.</li><li><strong>How fast will the CBO networks develop?</strong> Several vendors have revamped the <a href="https://medium.com/patchwiselabs/sdoh-buyers-guide-checklist-what-s-in-a-resource-directory-4a18ad42a5a0">Social Service Resource Directories</a> of yesterday into what are essentially ‘narrow networks’ of community partners. By vetting their quality and delivering an off the shelf stable of partners, companies are removing some of the risk for health plans. This trend is happening more broadly, such as in <a href="https://homehealthcarenews.com/2019/07/new-independent-home-care-alliance-to-work-on-industrys-dirty-little-secret/">home care</a>, and it will be a key one to monitor.</li><li><strong>How Creative will plans get to address SDOH?</strong> This is a rhetorical question, as the answer is most likely ‘not very.’ Year One will most likely see activity occurring with better-known cost/ROI items, e.g. home visits, rides, meals, and caregiving. But the rule about benefits doesn’t have any rules, outside of a “<em>reasonable expectation of improving or maintaining the health or overall function;” </em>These new SSBCI could theoretically promote a diversity of social supports and services, from peer supports to music therapy to <a href="https://newsinhealth.nih.gov/2018/02/power-pets">puppies on demand</a>.</li></ol><p><em>What do you think? What are you seeing or hearing related to new supplemental benefits? </em><a href="/service/mailto:hello@patchwiselabs.com"><em>Send us a note</em></a><em> to share your perspectives or questions.</em></p><p><em>This article originally appeared on the</em><a href="http://www.medium.com/patchwiselabs"><em> Patchwise Labs blog</em></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=975c2a14b348" width="1" height="1" alt=""><hr><p><a href="https://medium.com/tincture/friends-with-benefits-ma-plans-weigh-in-on-social-determinants-975c2a14b348">Friends with Benefits: MA Plans Weigh in on Social Determinants</a> was originally published in <a href="https://medium.com/tincture">Tincture</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Who, What, & How: Understanding New SDOH Payments in Medicare Advantage]]></title>
            <link>https://medium.com/tincture/who-what-how-understanding-new-sdoh-payments-in-medicare-advantage-8a8f7aed3140?source=rss-fc9c3de75975------2</link>
            <guid isPermaLink="false">https://medium.com/p/8a8f7aed3140</guid>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[health-policy]]></category>
            <category><![CDATA[medicare]]></category>
            <category><![CDATA[social-determinants]]></category>
            <category><![CDATA[innovation]]></category>
            <dc:creator><![CDATA[Naveen Rao]]></dc:creator>
            <pubDate>Mon, 22 Apr 2019 13:16:00 GMT</pubDate>
            <atom:updated>2019-04-22T13:16:00.997Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*iHX49XJz3P6ZKQR8.jpg" /><figcaption>Source: Commonwealth Fund</figcaption></figure><h4>Eligibility, Coverage, and Determination in SSBCI</h4><p>Earlier this month, the Centers for Medicare and Medicaid Services (CMS) <a href="https://www.cms.gov/newsroom/press-releases/cms-finalizes-medicare-advantage-and-part-d-payment-and-policy-updates-maximize-competition-and">finalized the rule</a> to allow Medicare Advantage (MA) plans to pay for certain non-clinical supports and services as “supplemental benefits” to address the social determinants of health (SDOH) for chronically ill patients.</p><figure><img alt="" src="https://cdn-images-1.medium.com/proxy/1*b4abq-O9Tjh20P3g8pZDdQ.png" /><figcaption>source: <a href="https://www.cms.gov/newsroom/press-releases/cms-finalizes-medicare-advantage-and-part-d-payment-and-policy-updates-maximize-competition-and">CMS.gov</a></figcaption></figure><p>The wonky acronym for the new rule: SSBCI, which stands for “special supplemental benefits for the chronically ill.” The punchline is easier to understand: MA plans can pay for meals, transportation, home modifications, pest control, and other non-clinical stuff starting next year.</p><p>The vast majority of this new rule is very similar to CMS’ initial proposal, though the final reg contains some new clarity around how plans can determine which members qualify for these new benefits, as well as some new leeway around what types of benefits qualify. For the general nuts and bolts, our <a href="https://medium.com/patchwiselabs/the-2020-opportunity-medicare-advantage-as-a-market-for-sdoh-innovation-b337e7685cdb">summary from February</a> offers a quick recap of how this will work.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fupscri.be%2F582c01%3Fas_embed%3Dtrue&amp;dntp=1&amp;display_name=Upscribe&amp;url=https%3A%2F%2Fupscri.be%2F582c01%2F&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=upscri" width="800" height="400" frameborder="0" scrolling="no"><a href="https://medium.com/media/b38aab6dac72745bddf6773c7a051a4b/href">https://medium.com/media/b38aab6dac72745bddf6773c7a051a4b/href</a></iframe><p>With the rule finalized, the wheels are officially in motion for 2020. The MA industry has begun thinking about how to add these new supplemental benefits into their annual bids for CMS approval, and then deliver them to the members in need. Usually the devil is in the details, but here the devil’s in the doing: The rules here are pretty straightforward, but implementing them will be the challenge, especially in the first couple of years.</p><p>Let’s zoom out and take a look at what this means at the broadest level. For health plans, consultants, technology vendors, and community partners, there are three major facets to this new rule: <strong>Who</strong>, <strong>What</strong>, and <strong>How</strong>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/546/1*KXqopwPQzNiO8YtKbiT2yQ.png" /><figcaption>source: <a href="http://www.patchwiselabs.com/">Patchwise Labs</a> analysis</figcaption></figure><h3>Who: Determining Eligibility</h3><p>This is relatively straightforward: First, only members with a “qualifying chronic condition” <a href="https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/mc86c16b.pdf">from this list</a> (p. 5) qualify. This may seem like a tight leash at first glance, but click the list — it’s basically anything. CMS even points out that this list covers about 73% of the current MA population.</p><p>Secondly, in addition to making sure that members have been diagnosed with a condition from that list, MA Plans must <strong>also</strong> develop and maintain their own assessment that these members health status also meets three key criteria of the program:</p><blockquote>1) has one or more comorbid and medically complex chronic conditions that is life threatening or significantly limits the overall health or function of the enrollee;</blockquote><blockquote>2) has a high risk of hospitalization or other adverse health outcomes; and</blockquote><blockquote>3) requires intensive care coordination.”</blockquote><h4>✏️ Key Detail: Plans will have to have a “process” to match members with qualifying chronic conditions from the list to the three pronged definition above.</h4><p>Note that while plans do NOT have to submit this process in writing as part of their annual bid to CMS, they DO have to document their determination for each member who enrolls in SSBCI. Think of it as an internal policy mechanism or filter to screen in people in need of extra services or supports.</p><h4>✏️ Key Detail: For Certain Plans (e.g. <a href="https://medium.com/patchwiselabs/are-social-determinants-of-health-special-needs-3bfaee7ea86c">SNPs</a>), community-based partner organizations can help determine eligibility according to the MA plan’s particular process.</h4><h3>What: Determining Coverage</h3><p>CMS offers a lot of wiggle room here. The goal of this new rule was to provide plans with a lot of flexibility to determine which non-clinical supports they want to include. The criteria in this case amounts to a sniff test:</p><blockquote>“MA organizations have broad discretion in developing the items and services they may offer as SSBCI provided that the items or services have a reasonable expectation of improving or maintaining the health or overall function of the enrollee as it relates to the chronic illness”</blockquote><p>An update in the final rule is that plans WILL be allowed to offer benefits that include “capital or structural improvements” like in-home modifications that could improve or maintain health (e.g. walking ramps, tub handrails, etc.)</p><h4>✏️ Key Detail: Plans can spend whatever they want to on SSBCI, but they have to pay for it as a “non-zero direct medical cost.”</h4><p>In effect, SSBCI will count towards plans’ medical loss ratios as opposed to counting as administrative expenses.</p><h4>✏️ Key Detail: Plans must describe any new SSBCI in the plan benefits package (PBP) as part of their annual bid.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/744/1*9M7M4xKbvRnf7Cirjo_7tg.png" /><figcaption>Credit: HIT Consultant</figcaption></figure><h3>How: Determining Determinations (aka “Matching”)</h3><p>Here is where things get trickier. While a new waiver of “<a href="https://www.healthaffairs.org/do/10.1377/hblog20180702.641853/full/">uniformity requirements</a>” give MA plans more flexibility to customize benefits to the individual, they are not allowed to confer new benefits on any chronically ill member from the list. Instead, each customized benefit they’re not directly linked to “the process” above. For example, transportation or meals can’t be provided to every beneficiary who has a chronic condition — only those for whom it would improve their specific health condition.</p><p>CMS’s word of choice is “Determinations:”</p><blockquote>“There must be a <strong>determination</strong> by the MA plan that the non-primarily health related benefit will have a reasonable expectation of improving the chronic disease or maintaining the health or overall function of the enrollee receiving the benefit”</blockquote><blockquote>“MA plans may make these beneficiary-specific <strong>determinations</strong> using internal criteria”</blockquote><blockquote>“We expect MA plans to develop objective criteria (e.g. health risk assessments) and maintain detailed documentation for <strong>determining</strong> when one chronically ill enrollee is eligible for a particular service or item and another is not.”</blockquote><h4>✏️ Key Detail: MA plans will have to develop an internal “matching” process that accounts for two things: 1) What are the non-clinical needs of this person as related to their chronic condition? 2) Does a specific benefit match up with those non-clinical needs?</h4><p>As always, with great challenge comes great opportunity: While the compliance on filtering and matching will be onerous to stand up, it allows plans to develop their own unique approach to addressing SDOH at scale. In theory, could an MA plan use a <a href="https://medium.com/patchwiselabs/sdoh-buyers-guide-checklist-what-s-in-a-needs-assessment-screening-498b31085a75">PRAPARE assessment or other screening tool</a>to identify specific non-clinical needs instead of an HRA? Would a loneliness screening be used to match someone with a peer coach, or perhaps a culturally tailored benefit, like a Promotora?</p><h3>If You Build It…Will They Come?</h3><p>Just because CMS will allow plans to start paying for some new stuff, that doesn’t guarantee it will work smoothly in the real world.</p><p>Questions remain around member engagement and the nearly invisible line CMS has drawn between making sure people know about these new benefits (which is encouraged) and making sure plans are not using these new benefits to market their plans to people (which is illegal).</p><p>And while there is plenty of flexibility built into this new rule, the vast majority of MA plans are not likely to take a highly experimental approach (at least not early on) — so novel uses of this program will likely be a couple of years away. Anecdotally we’ve heard from consultants of all types across the budding SDOH industry who are now scrambling to gather data on the cost of providing <a href="https://medium.com/patchwiselabs/let-food-be-thy-medicine-an-ancient-idea-driving-the-business-of-food-innovation-in-health-care-3052b9a135cd">meals</a> and <a href="https://medium.com/patchwiselabs/new-cms-rules-for-non-emergency-transportation-who-wins-who-loses-d1f685603851">rides</a> (and so far, little else).</p><p>But over time, perhaps these new SSBCI will promote a diversity of social supports and services. CMS is running an experiment on <a href="https://www.cms.gov/newsroom/fact-sheets/value-based-insurance-design-model-vbid-fact-sheet-cy-2020">value-based insurance design</a> that will inform how some of these policies work n the real world. Moreover, as we saw <a href="https://medium.com/patchwiselabs/a-glimpse-into-the-near-future-of-financing-the-social-determinants-of-health-sdoh-95102ce31407">in-depth</a>, it’s quite difficult to put together a multi-year cost-benefit analysis on SDOH in MA given the speedbumps of an annual bidding cycle. The bidding process in general discourages risk-taking, and most plans (particularly smaller plans serving dual-eligibles) will <a href="https://medium.com/patchwiselabs/are-social-determinants-of-health-special-needs-3bfaee7ea86c">play it safe</a> to start.</p><p>The good news is that as tech-enabled service platforms start conquering the administrative “how” and moving from <a href="https://medium.com/patchwiselabs/proof-of-concept-to-proof-of-scale-making-sdoh-benefits-matter-2e723fac9cc9">proof of concept to proof of scale</a>, MA plans will hopefully have an easier time focusing on the who and the what: our most vulnerable patients, and their social determinants of health.</p><p><em>Naveen Rao is Managing Partner at </em><a href="http://www.patchwiselabs.com/"><em>Patchwise Labs</em></a><em>, a creative strategy firm focused on safety net innovation, where this </em><a href="https://medium.com/patchwiselabs/who-what-how-understanding-mas-new-sdoh-payments-7e4243a84941"><em>piece originally appeared</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8a8f7aed3140" width="1" height="1" alt=""><hr><p><a href="https://medium.com/tincture/who-what-how-understanding-new-sdoh-payments-in-medicare-advantage-8a8f7aed3140">Who, What, &amp; How: Understanding New SDOH Payments in Medicare Advantage</a> was originally published in <a href="https://medium.com/tincture">Tincture</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[At a Glance: New Z-Codes for SDOH]]></title>
            <link>https://medium.com/tincture/at-a-glance-new-z-codes-for-sdoh-c8b2260e0fe3?source=rss-fc9c3de75975------2</link>
            <guid isPermaLink="false">https://medium.com/p/c8b2260e0fe3</guid>
            <category><![CDATA[health-policy]]></category>
            <category><![CDATA[social-determinants]]></category>
            <category><![CDATA[data]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[innovation]]></category>
            <dc:creator><![CDATA[Naveen Rao]]></dc:creator>
            <pubDate>Fri, 19 Apr 2019 18:54:09 GMT</pubDate>
            <atom:updated>2019-04-19T18:54:09.124Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/proxy/0*loqVlPmZrniIeHpQ.jpg" /></figure><h4>A handy guide to commenting on proposed ICD-10 changes</h4><p>The biggest headline this month for Social Determinants of Health (SDOH) Innovators was the announcement that UnitedHealthcare (UHC) and the American Medical Association (AMA) proposed a new set of ‘Z-codes’ for the ICD-10 coding system used in clinical diagnosis and billing at virtually every health insurer and doctor’s office across the country.</p><p><em>Some background reading on </em><a href="https://www.fortherecordmag.com/archives/0517p14.shtml"><em>Z-codes</em></a><em> and </em><a href="https://en.wikipedia.org/wiki/ICD-10"><em>ICD-10</em></a></p><p>If approved by the Centers for Disease Control and Prevention (CDC), these new codes represent a much more granular approach to documenting SDOH. If enacted and adapted properly, this would enable more precise and relevant social interventions for patients and families, more efficient use of existing resources and programs, and a better sense of <a href="https://medium.com/patchwiselabs/proof-of-concept-to-proof-of-scale-making-sdoh-benefits-matter-2e723fac9cc9">SDOH’s role</a> in value-based care payment/performance models.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fupscri.be%2F582c01%3Fas_embed%3Dtrue&amp;dntp=1&amp;display_name=Upscribe&amp;url=https%3A%2F%2Fupscri.be%2F582c01%2F&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=upscri" width="800" height="400" frameborder="0" scrolling="no"><a href="https://medium.com/media/b38aab6dac72745bddf6773c7a051a4b/href">https://medium.com/media/b38aab6dac72745bddf6773c7a051a4b/href</a></iframe><p>As with most health IT policy, SDOH data integration has many <a href="https://www.redoxengine.com/blog/policy-sdoh-data-integration/">wrinkles</a>; expanding ICD-10 Z-codes at a time when SDOH innovation is still finding its legs is fraught with potential shortcomings or missteps. We’ll save that commentary for elsewhere — the remainder of this article is dedicated to serving as a resource for any parties interested in submitting a comment in support of or amendment to the proposed codes.</p><p>We reviewed the proposed codes from the CDC’s <a href="https://www.cdc.gov/nchs/icd/icd10cm_maintenance.htm">National Center for Health Statistics</a> and organized them into the below table. The ICD-10’s Coordination and Maintenance Committee is in charge of reviewing all public comments,<strong>which need to be sent by May 10, 2019</strong> to the <a href="/service/mailto:nchsicd10CM@cdc.gov">Committee’s e-mail address.</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/866/1*H8nU7FipRW4Nh--Zqs2bZw.png" /><figcaption>note: Yellow shading indicates the newly proposed z-codes</figcaption></figure><h4>A Few Notes:</h4><ul><li>We were pleasantly surprised to learn that the headlines and retweets missed the full story: There were actually <a href="https://www.cdc.gov/nchs/data/icd/Topic-packet-March-2019-Part-2Vs3.pdf">two proposals</a> for expanding Z-Codes: One from UHC and AMA, and another from a team led by BCBS of Vermont and the Yale School of Nursing. The latter focused on codes related to Food Insecurity across Categories Z59, Z71, and Z91. We’ve put them together and organized by code in the table above.</li><li>If you’re wondering what to comment on, anything is fair game. Which codes are a good idea to move forward with? Which should be dropped? Are there certain proposed items that belong in other code sets or standards? That being said, the Committee will not accept any new proposals submitted during this comment period (that will have to wait until the September 2019 meeting)</li><li>Comments will be reviewed in May and final decisions will be made in June/July. It’s worth noting that any new codes that are accepted will not go into effect until October 2020.</li><li>We will continue exploring these new codes in the weeks ahead to analyze new use cases they may enable, potential problems they may introduce, and everything in between. If you have questions or comments you would like to share with us please send us a note: <strong>hello@patchwiselabs.com</strong></li></ul><p><em>Naveen Rao is Managing Partner at </em><a href="http://www.patchwiselabs.com/"><em>Patchwise Labs</em></a><em>, a creative strategy firm focused on safety net innovation, where this </em><a href="https://medium.com/patchwiselabs/at-a-glance-new-z-codes-for-sdoh-5368f354c769"><em>piece originally appeared</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c8b2260e0fe3" width="1" height="1" alt=""><hr><p><a href="https://medium.com/tincture/at-a-glance-new-z-codes-for-sdoh-c8b2260e0fe3">At a Glance: New Z-Codes for SDOH</a> was originally published in <a href="https://medium.com/tincture">Tincture</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[#HealthPolicyValentines: A love letter to SDOH Innovation ❤️]]></title>
            <link>https://medium.com/tincture/healthpolicyvalentines-a-love-letter-to-sdoh-innovation-%EF%B8%8F-6d6b9b004564?source=rss-fc9c3de75975------2</link>
            <guid isPermaLink="false">https://medium.com/p/6d6b9b004564</guid>
            <category><![CDATA[medicare]]></category>
            <category><![CDATA[social-determinants]]></category>
            <category><![CDATA[empathy]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[medicaid]]></category>
            <dc:creator><![CDATA[Naveen Rao]]></dc:creator>
            <pubDate>Thu, 14 Feb 2019 01:03:31 GMT</pubDate>
            <atom:updated>2019-02-14T01:03:31.063Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/940/0*BV234Z2uMchl-WwB" /></figure><blockquote>❤️</blockquote><blockquote>️Roses are red, and violets are blue;</blockquote><blockquote><a href="https://medium.com/patchwiselabs/introduction-healthcare-is-shifting-upstream-92333abe4d4d">The Social Determinants hype now seems true</a>.</blockquote><blockquote>On this Ides of February, halfway through:</blockquote><blockquote>A half-full, whole-hearted love note to you.</blockquote><blockquote>❤️❤️</blockquote><blockquote>“SDOH” — You maddening muse!</blockquote><blockquote>Common sense about health just won’t make the news.</blockquote><blockquote>Our safety net frayed,</blockquote><blockquote>A promise decayed;</blockquote><blockquote>Then you waltzed into my life, all <a href="https://www.politico.com/agenda/story/2018/09/12/medicare-preventative-social-needs-000688">toothpaste and shoes</a>.</blockquote><blockquote>❤️❤️❤️</blockquote><blockquote>A “<a href="https://pfs.urban.org/pay-success/pfs-perspectives/new-way-solving-old-problem-underinvestment-social-determinants-health">wrong pocket problem</a>,” you said from the start.</blockquote><blockquote>Innovation is science, but caring is art.</blockquote><blockquote>You caught my intrigue -</blockquote><blockquote>You’re in your own league.</blockquote><blockquote>Their interest may <a href="https://medium.com/patchwiselabs/state-level-policies-and-programs-addressing-sdoh-8e140db06e63">Waiver</a>, but you had my heart.</blockquote><blockquote>❤️❤️❤️❤️</blockquote><blockquote>Some data, some demos, and some dollars later:</blockquote><blockquote>The <a href="https://medium.com/patchwiselabs/announcing-the-2018-buyers-guide-to-social-innovation-tech-for-health-a3777181334e">rise of the vendor </a>as “upstream innovator.”</blockquote><blockquote>New markets to pick:</blockquote><blockquote>SNAP, NEMT and WIC!</blockquote><blockquote>I <a href="https://tincture.io/5-insights-on-the-emerging-market-for-social-innovation-technology-in-health-501e14d9a855">screened and referred you</a> and tuned out the haters.</blockquote><blockquote>❤️❤️❤️❤️❤️</blockquote><blockquote>In 2019, the upside looks fair:</blockquote><blockquote>New moves from each hospital, pharmacy, payer.</blockquote><blockquote>In my rose colored eyes,</blockquote><blockquote>You’ve got huge ROIs ;)</blockquote><blockquote>Let’s teach the market to measure and manage to care.</blockquote><blockquote>❤️❤️❤️❤️❤️❤️</blockquote><blockquote>But the more hope I pile on, the more that I fear:</blockquote><blockquote>What if your luster fades away in a year?</blockquote><blockquote>The political gaming,</blockquote><blockquote>and blaming, and shaming -</blockquote><blockquote>Can <a href="https://medium.com/patchwiselabs/unaddressed-social-determinants-of-health-are-breaking-the-bank-6f520e6a42f7">framing your value</a> make everything clear?</blockquote><blockquote>❤️❤️❤️❤️❤️❤️❤️</blockquote><blockquote>So here I will leave it: If it turns out you’ve lied,</blockquote><blockquote>And paid for my love with a meal and a ride,</blockquote><blockquote>And the numbers don’t work, despite how we tried,</blockquote><blockquote>I still think you’re worth it; I won’t leave your side.</blockquote><blockquote>❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️</blockquote><p><em>Naveen Rao is Managing Partner at </em><a href="http://www.patchwiselabs.com/"><em>Patchwise Labs</em></a><em>, a creative strategy firm focused on safety net innovation, where </em><a href="https://medium.com/patchwiselabs/the-2020-opportunity-medicare-advantage-as-a-market-for-sdoh-innovation-b337e7685cdb"><em>this piece originally appeared.</em></a></p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fupscri.be%2F582c01%3Fas_embed%3Dtrue&amp;dntp=1&amp;display_name=Upscribe&amp;url=https%3A%2F%2Fupscri.be%2F582c01%2F&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=upscri" width="800" height="400" frameborder="0" scrolling="no"><a href="https://medium.com/media/b38aab6dac72745bddf6773c7a051a4b/href">https://medium.com/media/b38aab6dac72745bddf6773c7a051a4b/href</a></iframe><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6d6b9b004564" width="1" height="1" alt=""><hr><p><a href="https://medium.com/tincture/healthpolicyvalentines-a-love-letter-to-sdoh-innovation-%EF%B8%8F-6d6b9b004564">#HealthPolicyValentines: A love letter to SDOH Innovation ❤️</a> was originally published in <a href="https://medium.com/tincture">Tincture</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The 2020 Opportunity: Medicare Advantage as a Market for SDOH Innovation]]></title>
            <link>https://medium.com/tincture/the-2020-opportunity-medicare-advantage-as-a-market-for-sdoh-innovation-75930afb285?source=rss-fc9c3de75975------2</link>
            <guid isPermaLink="false">https://medium.com/p/75930afb285</guid>
            <category><![CDATA[innovation]]></category>
            <category><![CDATA[public-health]]></category>
            <category><![CDATA[medicare]]></category>
            <category><![CDATA[social-determinants]]></category>
            <category><![CDATA[healthcare]]></category>
            <dc:creator><![CDATA[Naveen Rao]]></dc:creator>
            <pubDate>Sun, 10 Feb 2019 22:43:52 GMT</pubDate>
            <atom:updated>2019-02-10T22:43:52.755Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/906/0*3bXEfhs9ehfRe9EQ" /></figure><h4>Supplemental Benefits Never Sounded So Good</h4><p>Starting in 2020, Medicare Advantage plans will be allowed to offer supplemental, “non-primarily health-related” benefits to help certain eligible chronically ill patients with unmet social needs. Put simply, this represents a large source of reimbursement for social determinants of health (SDOH) solutions in the high-growth MA market.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fupscri.be%2F582c01%3Fas_embed%3Dtrue&amp;dntp=1&amp;display_name=Upscribe&amp;url=https%3A%2F%2Fupscri.be%2F582c01%2F&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=upscri" width="800" height="400" frameborder="0" scrolling="no"><a href="https://medium.com/media/b38aab6dac72745bddf6773c7a051a4b/href">https://medium.com/media/b38aab6dac72745bddf6773c7a051a4b/href</a></iframe><p>While this represents a real opportunity for SDOH innovators, we are at an early stage of the rulemaking process where there are far more questions than answers. The Centers for Medicare and Medicaid Services (CMS) recently issued a <a href="https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/Advance2020Part2.pdf">draft CY 2020 Call Letter</a> that provides guidance on the new rules.</p><h4>Making the Sausage: MA + SDOH = SSBCI</h4><p>There are actually two new, and slightly different updates to the supplemental benefits provision under MA. In 2018, CMS announced they would expand reimbursements starting this year (2019) in the MA program for non-clinical supports that promote the health of chronically ill beneficiaries who meet certain eligibility criteria.</p><p>Importantly, this 2019 update does not directly authorize benefits that address broader SDOH. The 2019 expansion will be focused tightly on “primarily health-related benefits” like adult day care, caregiver support, in-home supports, home safety modifications and more.</p><p>The bill did however, relax the program’s “uniformity requirements” to allow more customized services not only by diagnosis, but also by health status. For certain beneficiaries with complex needs this <a href="https://www.healthaffairs.org/do/10.1377/hblog20180702.641853/full/">could include</a> “Z codes” in ICD-10 that document non-clinical needs, such as assistance with self-care, living alone, or living with a dependent relative.</p><p>The bigger news for SDOH innovators starts in 2020, and comes with a fun new acronym for your deck of flashcards: SSBCI.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/919/0*JfRv8G3laB-vivkM" /></figure><h3>Introducing: Special Supplemental Benefits for the Chronically Ill (SSBCI)</h3><p>Starting in 2020, SSBCI will amend the 2019 requirements to encompass “supplemental benefits that are not primarily health related and/or offered non-uniformly to eligible chronically ill enrollees […] if certain conditions are met.”</p><p>The new outlook for SSBCI, albeit from early on in the rule-making process, appears to offer a broad, flexible set of conditions for innovators and health plans to explore product/market fits for new approaches to address the SDOH. It’s not quite a blank canvas, so let’s take a look at the policy more closely to get a better sense of the business opportunity here.</p><h4>Product: What Counts as an SSBCI?</h4><p>If you’re wondering what “not primarily health related” jargon means in plain English, CMS’s explanation may not help:</p><blockquote>“MA plans will have the ability to offer a “non-primarily health related” item or service to chronically ill enrollees if the SSBCI has a <strong><em>reasonable expectation of improving or maintaining the health or overall function of the enrollee</em></strong> as it relates to the chronic disease.” (note: this is CMS’s emphasis, not our own <em>🤔</em>)</blockquote><p><strong>Examples of what SSBCI could be:</strong> “Such items and services may include, but are not limited to, transportation for non-medical needs, home-delivered meals (beyond the current allowable limited basis), food and produce.”</p><p><strong>Examples of what SSBCI cannot be</strong>: “capital or structural improvements to the home of the enrollee that could potentially increase property value (e.g., permanent ramps, and widening hallways or doorways)…Additionally, items and services may not be offered to induce enrollment.”</p><p><strong>Examples of what SSBCI maybe could be but only time will tell</strong>: More broadly, this new ruling has been intentionally designed to provide plans with “broad discretion” — might we see dollars open up for peer supports, CHW, culturally tailored services, financial assistance, or even pet therapy?</p><h4>Market: Which Beneficiaries (and How Many) are Eligible?</h4><p>If defining what will be paid for is one key variable in this equation, then the other is defining who is eligible. From the regulation:</p><blockquote>“Section 1852(a)(3)(D)(ii), as amended, defines a chronically ill enrollee as an individual who:</blockquote><blockquote>1) has one or more comorbid and medically complex chronic conditions that is life threatening or significantly limits the overall health or function of the enrollee;</blockquote><blockquote>2) has a high risk of hospitalization or other adverse health outcomes; and</blockquote><blockquote>3) requires intensive care coordination.”</blockquote><p>As far as what counts as a “chronic condition”, CMS points to the <a href="https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/mc86c16b.pdf">Medicare Managed Care Manual</a> (section 20.1.2 starting on page 5). It’s a broad list spanning metabolic conditions, cancers, rare diseases, behavioral and mental illnesses, substance abuse and more.</p><p>So, how big of a market opportunity is this? That is, as yet, unclear — for a few reasons.</p><p>First, it’s uncertain how many plans will actually offer these expanded benefits. All signs point to strong interest from the MA market, but the specific numbers <a href="https://www.bettermedicarealliance.org/newsroom/bma-blog/uptake-new-medicare-advantage-supplemental-benefits-2019">vary</a> <a href="https://avalere.com/press-releases/medicare-advantage-beneficiaries-will-see-a-jump-in-new-supplemental-benefit-offerings-in-2019">drastically</a> based on the types of benefits in question. Secondly, given the substantive policy changes described above, any trend from 2018 to 2019 will have little bearing on the number of plans expanding their offerings between 2019 and 2020.</p><p>While the number of people and health plans impacted by this will become clear with the passage of time, there are some deeper-rooted challenges here that might not.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/940/0*tbjWx_GbkKeaeOtz" /></figure><h4>Deeper Challenges: Money &amp; Member Engagement</h4><p>While MA represents a buzzy market to PE and VC, one thing is important to understand: This is not “new money,” it’s a redistribution of existing dollars. CMS is not offering additional funding for new supplemental benefits, but rather providing plans with more flexibility to match resources to needs.</p><p>In some ways this new approach resembles a simplified “pay for success” scheme, wherein CMS is allowing MA plans to front the cost of social intervention, prove a positive impact on health, and then promising them a reimbursement. The economics might work out here, but the math is still unclear on how which services are covered, how much they cost, what rate they’re billed, how rigorous CMS intends to be in adjudicating claims, and so on.</p><p>For innovators, the Letter states that MA plans must incur “a non-zero direct medical cost” for all supplemental benefits, meaning that in order to be reimbursed for providing a ride or a meal, a plan must invest those dollars into a specific preventative, rehabilitative, or otherwise “reasonable” health impact.</p><p>This small clause carries serious potential implications for innovators. If new SSBCIs can only be counted as non-administrative costs, will plans be reimbursed for investing in new technology, or will that count as an administrative expense? The Call Letter hints that CMS’s expectation is that plans make investments in the enabling technology systems on their own:</p><blockquote>“MA plans to develop objective criteria (e.g., health risk assessments) and maintain detailed documentation for determining when one chronically ill enrollee is eligible for a particular item or service and another is not. Note that maintaining detailed internal documentation is necessary to address potential beneficiary appeals, complaints, and/or general oversight activities performed by CMS.”</blockquote><p>Moreover, the program is entirely voluntary. All of this simply adds up to the likelihood that despite the additional spending leeway from CMS, there are no dedicated budgets and guidelines for 3rd party solutions ala the gold rush days of the HITECH Act. SDOH Innovators are likely to face a competitive sales process requiring a lot of customer education, demos, and brand differentiation.</p><p>In some ways the MA market opportunity for SDOH innovation may look more like the world of Medicaid MCOs: reimbursement conditions vary from state to state and county to county; those who can do well in one will likely enjoy success in the other.</p><p>One of the biggest logistical wrinkles here might be member engagement. Take for instance, CMS’s requirement that plans cannot “induce enrollment” by promoting benefits — this may undermine plans’ ability to drive awareness of the new benefits among seniors or duals, which could <a href="https://khn.org/news/trumpeted-new-medicare-advantage-benefits-will-be-hard-for-seniors-to-find/">undermine engagement</a> and ultimately utilization. If a consumer needs a ride, shouldn’t they be able to pick a health plan accordingly?</p><p>As a government program, CMS mandates all these new benefits are subject to ongoing coverage decisions, denials, appeals, etc. None of this sounds consumer friendly or easy to use, and in the first few years of MA plans figuring this out, you can bet it’s not going to go smoothly all of the time.</p><p>A related tangled web is the role of community partners. CMS allows for community based organizations (CBOs) to have a seat at the table to do things like help determine eligibility and deliver support, but it won’t reimburse plans for services rendered by CBOs. Not only is this shortsighted given how much work and how little money these organizations receive, but it adds incredible confusion to the member experience as far as who is responsible for arranging, delivering, measuring, making decisions, and so on.</p><h3>2020 &amp; Beyond: Legislation → Law + Innovate → ROI</h3><p>As part of this rule, Congress is authorizing a five year study by the General Accountability Office (GAO) to analyze frequency of utilization, impact on quality of care, clinical outcomes, and the impact on plans bidding rates for Part C. The report will go on to inform subsequent decisions on funding SDOH supports, ultimately influencing their expansion into Medicare or other insurance programs.</p><p>However, given that the US still lacks a definitive sense of what constitutes “ROI” when it comes to social determinants — this report could either become a landmark study, a political football, a red herring or some combination of the above. The closest thing to a crystal ball on this front may be data from the Center for Medicare and Medicaid Innovation (CMMI), which just announced an expansion of its Value-Based Insurance Design (VBID) Model, that also <a href="https://www.cms.gov/newsroom/fact-sheets/value-based-insurance-design-model-vbid-fact-sheet-cy-2020">incorporates</a> supplemental benefits based on chronic conditions, or based only on socioeconomic status.</p><p>According to the Call Letter, CMS is looking for input from stakeholders by March 1st in two areas:</p><blockquote>1. “ CMS solicits comment on whether plans should have flexibility to determine what is a chronic condition that meets the statutory standard (“is life threatening or significantly limits the overall health or function of the enrollee”) and if CMS should consider alternative approaches to determining what meets this criterion.”</blockquote><blockquote>2. “CMS is soliciting comments on the limits of these supplemental benefits discussed here and whether we should permit consideration of other factors, like financial need, in determining permissible supplemental benefits for chronically ill enrollees.”</blockquote><p>Beyond these areas, there are several other items that we’d like to see more clarification on, including some of the key language (“reasonable expectation”) as well as how plans should think about investing in new technology and business partnerships in light of meeting the new SSBCI criteria.</p><p>Zooming out, CMS states the “intended purpose of the new category of supplemental benefits is to enable MA plans to better tailor benefit offerings for the chronically ill population, address gaps in care, and improve specific health outcomes.” To that end, we’ll be keeping an eye on this issue as it develops over the course of the year.</p><p><em>We’d love to hear your questions, comments, and other feedback! <br></em><a href="https://medium.com/patchwiselabs/the-2020-opportunity-medicare-advantage-as-a-market-for-sdoh-innovation-b337e7685cdb"><em>This piece originally appeared at Patchwise Labs</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=75930afb285" width="1" height="1" alt=""><hr><p><a href="https://medium.com/tincture/the-2020-opportunity-medicare-advantage-as-a-market-for-sdoh-innovation-75930afb285">The 2020 Opportunity: Medicare Advantage as a Market for SDOH Innovation</a> was originally published in <a href="https://medium.com/tincture">Tincture</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>